Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

NCT01838681 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1986

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Placebo
DRUG: Brexpiprazole
DRUG: ADT

Sponsor

H. Lundbeck A/S

Collaborators

[object Object]